Search results for: 'cell and gene therapy cold chain'

Macro cells are the workhorse of most CSP networks. With higher output power, they cover larger areas and provide most of the coverage and capacity of the 5G network. Most macro cells now provide outdoor coverage, but in the past, they provided indoor coverage as well. However, wireless coverage based on macro cells can have coverage issues caused ...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

02 Sep 2015  |  Global  |  Market Research

The New Age of Regenerative Medicine

Why Stem Cell Therapy?

Infographics

×

Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases suc...

Software supply chain security (SSCS) is increasingly a strategic business imperative as organizations rely more on open-source software, cloud-native architectures, AI-driven development, and autonomous development workflows. Modern software supply chains now extend beyond traditional code repositories and development pipelines to include AI model...

21 Jan 2025  |  Global  |  Technology Research

Technologies Enabling Resilient Pharmaceutical Supply Chains

AI-enabled Technologies are Transforming the Pharmaceutical Supply Chain Network

Infographics

×

This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model. The study answers the following questions: What are some new challenges big pharma's supply chains must address today? How can emerging tec...

The current research study discusses the available countermeasures and forthcoming allergic and infectious diseases. The most common allergic diseases such as allergic rhinitis, also know as Hay fever or seasonal allergies; sinusitis; asthma and chronic obstructive pulmonary disease (COPD); atopic dermatitis (or eczema); urticaria (or hives) and mo...

The accelerating transition to net-zero emissions and demand for high-efficiency renewable energy are driving the need for photovoltaic technologies that surpass the performance limits of conventional crystalline silicon solar cells. As single-junction crystalline silicon solar cells approach their practical efficiency limits, perovskite-silicon ta...

As businesses digitize, the uptake of applications has been inevitable. Digital transformation has boosted the demand for innovation among software producers and software development life cycle (SDLC) developers in order to meet business goals. As a result, software producers are either migrating their services, assets, and applications to cloud en...

Rife geopolitical tensions and multiple external shocks during the past few years have been rapidly transforming global supply chains and pushing firms to take strategic site-selection decisions. The need for economic resiliency is fostering a paradigm shift as companies are directing investments into the establishment of local and regional manufac...